Envisioning the Dual Repercussions of FDA’s Accelerated Approval Pathway


Clinical trials are comprehensive research studies conducted to ensure that recently developed medical interventions, including novel drugs, surgical & other devices, and treatments/ therapies, are safe and effective for human use before commercialization. These trials provide evidence for regulatory bodies like the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, UK’s Medicines and Healthcare Products Regulatory Agency, and China’s National Medical Products Administration (NMPA) to ensure that a specific medical intervention is safe for the public use, begets limited adverse effects, and meets quality standards. However, it takes 10 to 15 years or even more to complete all three clinical trial phases before reaching the licensing stage. Thus, FDA introduced accelerated or expedite approvals to pace up the approval of drugs that treat severe conditions and address unmet medical needs.

Before proceeding with the pros and cons of the FDA’s expedited program, let’s first understand the full-fledged approval process set by various regulatory agencies to launch any novel medical interventions in the market after comprehensive analysis.

 

  • Pre-Approval: the regulatory agencies set specific guidelines around study design, volunteer selection, monitoring procedures, informed consent, and data collection, which pharmaceutical industries must adhere to when conducting clinical trials.

 

  • Investigational New Drug (IND) Application: Drugmakers/ sponsors are obliged to submit an IND application to the regulatory body before initiating a clinical trial. This application comprises justification, proposed study design, safety data from pre-clinical studies, and a feasible approach to monitor volunteers during the trial.

 

  • Review Process: The regulatory agency thoroughly reviews the statistical data, data quality, results of all phases of pre-clinical and clinical trials, and potential benefits & risks associated with the particular intervention.

 

  • Post-Approval: Even after granting approval for marketing and commercializing medical interventions, the regulatory body continues to monitor the safety and efficacy of approved products through post-marketing surveillance and requires periodic reporting of adverse events.

 

Need for introducing USFDA Accelerated Approval Program
The US FDA’s Accelerated Approval Program (AAP) aims to expedite the development and enable faster access to new therapies that address an unmet need in treating severe ailments. This program is mainly introduced to promote the treatment of chronic diseases, where the course of the condition is extended, and determining the clinical endpoint would take considerable time. The primary objective behind introducing a priority review of specific drugs for accelerated approval is to launch the drugs earlier in the market. To justify, in the case of chronic diseases like HIV and cancer, thoroughly understanding the effect of medications with precision can take a long time, which results in delayed drug approval.

Click below to read the complete article by ‘IEBS’@
https://www.iebrain.com/dual-repercussions-of-fdas-accelerated-approval-pathway/

About Ingenious e-Brain Solutions: -

Ingenious e-Brain Solutions provides high-quality, customized, and cost-effective Technology Intelligence, Business Intelligence, and Intellectual Property Intelligence solutions to industry leaders, and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality results ensuring fool-proof confidentiality and security. We are an ISO certified company with offices in India and USA.

Ingenious e-Brain Solutions has a strong team of analysts, and subject matter experts with domain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-added and cost-effective services to our clients. We believe in building long term relationships with our clients who include national and international corporations, Fortune 500 companies, world’s leading research institutes and universities as well as independent inventors.

Get in Touch: -
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218

Email: -
queries@iebrain.com

Comments

Post a Comment

Popular posts from this blog

Blue Ocean Strategy: A Game Changer for Your Business

Image
Are you tired of competing in a crowded market where everyone fights for the same customers? It's time to explore the Blue Ocean Strategy. Are you looking to create new market space and make the competition irrelevant? Do you want to unlock new opportunities for growth and profitability? If so, you need to embrace the Blue Ocean Strategy. At Ingenious E-Brain, we understand that the Blue Ocean Strategy is not just a buzzword but a proven framework for creating new demand in an uncontested market space. Our consulting firm has extensive experience helping businesses across industries develop and implement Blue Ocean Strategies that drive growth and profitability. Our team of experts can help you identify untapped market opportunities, develop unique value propositions, and create new demand through strategic differentiation. We leverage cutting-edge tools and techniques to help you break free from the competition and achieve sustainable growth. Whether you are a startup loo
Read more

Encapsulation Materials for Micro LED - IEBS Case Study

Image
Micro-LED without encapsulation materials cannot meet the requirements to use; thus, a specific encapsulation is needed to provide mechanical protection, effective heat dissipation, electric connections, and high efficiency and quality light output. The encapsulation forms used on micro-LEDs are: ·   Chip-type SMD encapsulation ·   N-in-one IMD encapsulation ·   COB encapsulation The Challenge The demand for high-power micro-LED is growing exponentially, so it becomes more relevant to increase the demand for encapsulation materials. The micro-LEDs are used in devices to enhance their efficiency and provide high brightness, which comes with the challenges like heat dissipation, outside protection, and transparent surface. High-power micro-LEDs have an advantage in the automotive application and general lighting owing to efficient working for extended operating hours and low maintenance costs. For micro-LEDs, organic encapsulant materials used are acrylic resin, epoxy resin,
Read more

Medical Device Companies Can Meet The Increasing Demand For Improved Medical Equipment By Adopting IEBS-derived Strategic Solutions

Image
Overview: The biomedical industry, an evolving healthcare industry segment, can phenomenally revolutionize the healthcare device market. With the significant technological developments in surgical devices, implants, bioprinting, imaging methods, and much more, the biomedical industry is bridging the gap between biological science, medicine, and engineering. Potential Opportunities Across Biomedical Industry: In an era of value-based delivery model, patients are now opting for treatments with minimally invasive procedures, which minimizes in-patient hospital stay and reduces healing time, thus reducing overall healthcare expenditure. For performing surgeries with the least incisions, such as pacemaker implantation, angioplasty, or smart drug delivery devices integration, among others; highly sophisticated devices loaded with various sensors & camcorders are a mandate. Hence, a rapid increase in demand for such advanced medical equipment across multiple tertiary healthcare cent
Read more